Rahmi Aslan, “Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B”, Turkish Journal of Gastroenterology, vol. 34, no. 2, pp. 156–160, Feb. 2023.